Journal
ANALYTICAL CHEMISTRY
Volume 94, Issue 35, Pages 12033-12041Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.2c01590
Keywords
-
Categories
Ask authors/readers for more resources
In this study, a FFF-MALS method was developed for the characterization of OMVs, and NIST-traceable particle-size standards and BSA were used for validation. The validation results showed excellent accuracy and reliability of the method. Furthermore, the validated method was used for the characterization of a purification process and different OMVs from bacterial origin. Lastly, functionalization of OMVs did not affect their structural integrity, as evaluated by the validated FFF-MALS method.
With the ongoing development of conjugate vaccines battling infectious diseases, there is a need for novel carriers. Although tetanus toxoid and CRM197 belong to the traditional carrier proteins, outer-membrane vesicles (OMVs) are an excellent alternative: in addition to their size, OMVs have selfadjuvanting properties due to the presence of genetically detoxified lipopolysaccharide (LPS) and are therefore ideal as a vaccine component or antigen carrier. An essential aspect of their development for vaccine products is characterization of OMVs with respect to size and purity. We report on the development of a field-flow fractionation multiangle light-scattering (FFF-MALS) method for such characterization. Here, we introduced NIST-traceable particle-size standards and BSA as a model protein to verify the precision of the size and purity analysis of the OMVs. We executed a validation program according to the principles provided in the ICH Guidelines Q2 (R1) to assess the quality attributes of the results obtained by FFF-MALS analysis. All validation characteristics showed excellent results with coefficients of variation between 0.4 and 7.32%. Estimation of limits of detection for hydrodynamic radius and particle concentration revealed that as little as 1 mu g OMV still yielded accurate results. With the validated method, we further characterized a full downstream purification process of our proprietary OMV. This was followed by the evaluation of other purified OMVs from different bacterial origin. Finally, functionalizing OMVs with N-gamma-(maleimidobutyryl)-oxysuccinimide-ester (GMBS), generating ready-to-conjugate OMVs, did not affect the structural integrity of the OMVs and as such, they could be evaluated with the validated FFF-MALS method.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available